期刊
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
卷 29, 期 11, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105182
关键词
COVID-19; Patients with stroke; Coagulopathy; Physical therapy Rehabilitation
资金
- Taipei Veterans General Hospital, Yuli branch [VHYL-108-01]
- Ministry of Science and Technology [108-2314-B-010 -042 -MY3]
- Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program [108-V-B-008]
Infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the development of the novel 2019 coronavirus disease (COVID-19) and associated clinical symptoms, which typically presents as an upper respiratory syndrome such as pneumonia. Growing evidence indicates an increased prevalence of neurological involvement (e.g., in the form of stroke) during virus infection. COVID-19 has been suggested to be more than a lung infection because it affects the vasculature of the lungs and other organs and increases the risk of thrombosis. Patients with stroke are vulnerable to secondary events as a result not only of their poor vascular condition but also of their lack of access to rehabilitation resources. Herein, we review current knowledge regarding the pathophysiology of COVID-19, its possible association with neurological involvement, and current drug therapies. Suggestions are also offered regarding the potential for current neurorehabilitation therapies to be taught and practiced at home.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据